Skip to main content
. 2021 Jan 13;11(1):50. doi: 10.3390/life11010050

Table 5.

Results of correlation analysis in the examined group of patients.

Glucose Insulin HOMA-IR
r p r p r p
AHI 0.15 ns 0.55 0.001 0.54 0.001
ODI 0.24 ns 0.61 0.001 0.61 0.001
TST −0.13 ns −0.02 ns −0.03 ns
SL −0.16 ns −0.09 ns −0.10 ns
REML 0.01 ns 0.24 ns 0.24 ns
WASO 0.18 ns −0.20 ns −0.15 ns
SE −0.07 ns 0.16 ns 0.13 ns
NREM1 0.14 ns 0.54 0.001 0.54 0.001
NREM2 −0.02 ns 0.17 ns 0.16 ns
NREM3 −0.01 ns −0.43 0.003 −0.42 0.004
REM −0.12 ns −0.27 ns −0.27 ns
Average SpO2 −0.11 ns −0.24 ns −0.25 ns
Minimal SpO2 −0.26 ns −0.29 ns −0.32 0.032
Spo2 < 90% 0.34 0.027 0.40 0.007 0.44 0.003
Average desat. drop 0.16 ns 0.46 0.002 0.47 0.001
H 0.02 ns 0.18 ns 0.17 ns
ESS −0.15 ns 0.10 ns 0.06 ns

HOMA-IR, homeostatic model assessment-insulin resistance index; AHI, apnea–hypopnea index; ODI, oxygen desaturation index; TST, total sleep time; SL, sleep latency; REML, REM latency; WASO, wake after sleep onset; SE, sleep efficiency; NREM1 stadium of non-REM sleep 1; NREM2, stadium of non-REM sleep 2; NREM3, stadium of non-REM sleep 3; REM, stadium of REM sleep; SpO2 < 90% (%), time with oxygen saturation < 90% (% of total bedtime; H, heart rate; ESS, Epworth sleepiness scale.